stella
beta
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors — Stella
Recruiting
Back to Neuroblastoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(6 sites)
United States
Children's Hospital of Alabama/UAB, Birmingham, Alabama
Children's Hospital of Colorado, Aurora, Colorado
Children's National Medical Center, Washington D.C., District of Columbia
Children's Hospital at Montefiore, The Bronx, New York
Nationwide Children's Hospital, Columbus, Ohio
Show all 6 locations
View full record on ClinicalTrials.gov